76 related articles for article (PubMed ID: 30646796)
1. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
[TBL] [Abstract][Full Text] [Related]
2. First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial.
Tian XP; Cai J; Xia Y; Zhang YC; Wang L; Liu PP; Huang HQ; Li YJ; Zhou H; Li ZM; Yang J; Wei LQ; Zou QH; Huang Y; Li J; Ling L; Zhong WL; Cai QQ
Lancet Haematol; 2024 May; 11(5):e336-e344. PubMed ID: 38554717
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study.
He SS; Wang Y; Bao Y; Cai XY; Yang XL; Chen DM; Chen Y; Lu LX
Cancer Med; 2018 Apr; 7(4):1110-1117. PubMed ID: 29493874
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase: a multicenter retrospective study].
Shen ZY; Chen XC; Shan HR; Jia T; Gu WY; Wang F; Teng QL; Wang L; Wang CL; Shi YY; Zhang H; Miao YQ; Zhu TG; Ji CY; Ye JJ; Zhang MZ; Zhang XD; Wang L; Xu KL; Sang W
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):642-648. PubMed ID: 37803837
[No Abstract] [Full Text] [Related]
5. How we treat NK/T-cell lymphomas.
Tse E; Zhao WL; Xiong J; Kwong YL
J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
[TBL] [Abstract][Full Text] [Related]
6. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.
Hayashino K; Yoshida C; Ayata Y; Yukawa R; Komura A; Nakamura M; Meguri Y; Yamamoto K; Oda W; Imajo K
J Clin Exp Hematop; 2024; 64(1):52-58. PubMed ID: 38538319
[TBL] [Abstract][Full Text] [Related]
7. Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature.
Porte J; Hennequin C; Krizch D; Vercellino L; Guillerm S; Thieblemont C; Quéro L
Strahlenther Onkol; 2024 May; 200(5):434-443. PubMed ID: 37945929
[TBL] [Abstract][Full Text] [Related]
8. Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series.
Zhang YH; Li Z; Zhao S; Zhang WY; Liu QL; Liu WP; Gao LM
Ann Hematol; 2023 Oct; 102(10):2803-2813. PubMed ID: 37434096
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphoma.
Shen Z; Chen X; Sun C; Lu T; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Zhang X; Wang L; Cai G; Sang W
Cancer Med; 2023 Dec; 12(23):21138-21147. PubMed ID: 37902266
[TBL] [Abstract][Full Text] [Related]
10. A case of clinically aggressive EBV-negative ENKTL in a non-Asian female patient.
Kent T; Scott G; Seifert R
J Hematop; 2023 Mar; 16(1):33-38. PubMed ID: 38175370
[TBL] [Abstract][Full Text] [Related]
11. EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome.
Kato S; Hamada M; Okamoto A; Yamashita D; Miyoshi H; Arai H; Satou A; Gion Y; Sato Y; Tsuyuki Y; Miyata-Takata T; Takata K; Asano N; Takahashi E; Ohshima K; Tomita A; Hosoda W; Nakamura S; Okuno Y
Blood Adv; 2024 May; 8(9):2138-2147. PubMed ID: 38429084
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV
Xing TY; Duan ZW; Wang WT; Du KX; Shen HR; Yin H; Wu JZ; Li Y; Wang L; Li JY; Liang JH; Xu W
Ann Hematol; 2023 Sep; 102(9):2471-2481. PubMed ID: 37160794
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL).
Rajendra A; Sengar M; Bonda VNA; Jain H; Nayak L; Thorat J; Shet T; Epari S; Laskar S; Aggarwal A; Rangarajan V; Gujral S; Bagal B; Kakoti S; Salvi O
Leuk Lymphoma; 2023 Dec; 64(12):1914-1926. PubMed ID: 37602660
[TBL] [Abstract][Full Text] [Related]
14. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus DNA measurement in skin tumor lesions might be a sensitive diagnostic marker of recurrence in patients with nasal-type extranodal NK/T-cell lymphoma: A case report.
Yokota N; Kondo M; Matsushima Y; Habe K; Yamanaka K
J Dermatol; 2023 Sep; 50(9):e285-e286. PubMed ID: 36938658
[No Abstract] [Full Text] [Related]
16. Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma.
Yoon SE; Cho H; Berning P; Cho J; Kim HY; Yoon DH; Schmit N; Kim SJ; Kim WS
Ann Hematol; 2024 May; ():. PubMed ID: 38730207
[TBL] [Abstract][Full Text] [Related]
17. A case of extranodal NK/T-cell lymphoma, nasal type, diagnosed by scraping cytology of the maxillary gingiva.
Niwa H; Mukai K; Kimura I; Imura J
Diagn Cytopathol; 2024 Feb; 52(2):E39-E43. PubMed ID: 37886876
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Prediction of Survival for Sinonasal Extranodal Natural Killer/T-cell Lymphoma.
Wang T; Qiu Y; Shi L; Chen D; Chen X; Liu J; Liu T
Laryngoscope; 2023 Jul; 133(7):1645-1651. PubMed ID: 37294046
[TBL] [Abstract][Full Text] [Related]
19. First-line immunotherapy with anti-PD-1 antibody for extranodal NK/T-cell lymphoma: A retrospective study.
Wang X; Wen L; Liao J; Feng Y; Li Y; Zhou Z; Zhou C; Huang H
Br J Haematol; 2023 Aug; 202(4):812-824. PubMed ID: 37394245
[TBL] [Abstract][Full Text] [Related]
20. EBV-associated NK and T-cell lymphoid neoplasms.
Kimura H; de Leval L; Cai Q; Kim WS
Curr Opin Oncol; 2022 Sep; 34(5):422-431. PubMed ID: 35900729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
